Assess whether to price to win or walk from a buy-in after a modification

SITUATION CMMC implementation lead in a lab competing a Phase II SBIR has one working extract — SBIR Phase II commercialization appendix — after a modification adding cybersecurity work not in the PWS. If SBIR Phase II commercialization appendix cannot support to price to win or walk, the only defensible Government RFP output is hold.

DECISION CMMC implementation lead in a lab competing a Phase II SBIR must choose To price to win / Walk from a buy-in using SBIR Phase II commercialization appendix after a modification adding cybersecurity work not in the PWS.

HYPOTHESES TO TEST 1. SBIR Phase II commercialization appendix reads as To price to win once a modification adding cybersecurity work not in the PWS is lined up to the same Government RFP population. 2. SBIR Phase II commercialization appendix is closer to Walk from a buy-in after a modification adding cybersecurity work not in the PWS; To price to win would over-claim this Capture and Pricing extract. 3. A dual reading is still live in SBIR Phase II commercialization appendix for CMMC implementation lead in a lab competing a Phase II SBIR. 4. SBIR Phase II commercialization appendix is missing the fact CMMC implementation lead needs after a modification adding cybersecurity work not in the PWS; stop this Government RFP close.

ANALYSIS REQUIRED 1. Compare teaming and past-performance claims to what SBIR Phase II commercialization appendix attaches. 2. Normalize pricing and exceptions against the solicitation that governs to price to win or walk. 3. Score competitive posture if CMMC implementation lead pursues, partners, or no-bids. 4. For this Government RFP Capture and Pricing file, read SBIR Phase II commercialization appendix against a modification adding cybersecurity work not in the PWS and write the one fact that would move to price to win or walk for CMMC implementation lead.

RECOMMENDATION Choose To price to win / Walk from a buy-in on this Government RFP / Capture and Pricing packet (SBIR Phase II commercialization appendix after a modification adding cybersecurity work not in the PWS). Lead with the Government RFP option SBIR Phase II commercialization appendix can support after a modification adding cybersecurity work not in the PWS, then the two facts that force it, then the Monday action for CMMC implementation lead in a lab competing a Phase II SBIR.

COMMAND RETURNS - Bottom-line Government RFP option on to price to win or walk, then the evidence in SBIR Phase II commercialization appendix, then the action for CMMC implementation lead - Hypothesis scorecard against SBIR Phase II commercialization appendix: supported / rejected / untestable - Named option among To price to win, Walk from a buy-in and the fact that kills the others - Owner and next date for CMMC implementation lead in a lab competing a Phase II SBIR